9-Valent human papillomavirus vaccine: a review of the clinical development program.

Andreas Billich, HPV vaccine MedImmune/GlaxoSmithKline. Current opinion in investigational drugs. ,vol. 4, pp. 210- ,(2003)

Pope Kosalaraksa, Jesper Mehlsen, Timo Vesikari, Aino Forstén, Klaus Helm, Pierre Van Damme, Elmar A. Joura, Karen Ciprero, Roger Maansson, Alain Luxembourg, Ajoke Sobanjo-ter Meulen, An open-label, randomized study of a 9-valent human papillomavirus vaccine given concomitantly with diphtheria, tetanus, pertussis and poliomyelitis vaccines to healthy adolescents 11-15 years of age. Pediatric Infectious Disease Journal. ,vol. 34, pp. 627- 634 ,(2015) , 10.1097/INF.0000000000000694

Alain Luxembourg, Darron Brown, Celine Bouchard, Anna R Giuliano, Ole-Erik Iversen, Elmar A Joura, Mary E Penny, Jaime A Restrepo, Josefina Romaguera, Roger Maansson, Erin Moeller, Michael Ritter, Joshua Chen, Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine. Human Vaccines & Immunotherapeutics. ,vol. 11, pp. 1313- 1322 ,(2015) , 10.1080/21645515.2015.1012010

C. Chao, N. P. Klein, C. M. Velicer, L. S. Sy, J. M. Slezak, H. Takhar, B. Ackerson, T. C. Cheetham, J. Hansen, K. Deosaransingh, M. Emery, K.-L. Liaw, S. J. Jacobsen, Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine Journal of Internal Medicine. ,vol. 271, pp. 193- 203 ,(2012) , 10.1111/J.1365-2796.2011.02467.X

Laia Alemany, Maëlle Saunier, Isabel Alvarado-Cabrero, Beatriz Quirós, Jorge Salmeron, Hai-Rim Shin, Edyta C. Pirog, Núria Guimerà, Gustavo Hernandez-Suarez, Ana Felix, Omar Clavero, Belen Lloveras, Elena Kasamatsu, Marc T. Goodman, Brenda Y. Hernandez, Jan Laco, Leopoldo Tinoco, Daan T. Geraets, Charles F. Lynch, Vaclav Mandys, Mario Poljak, Robert Jach, Josep Verge, Christine Clavel, Cathy Ndiaye, JoEllen Klaustermeier, Antonio Cubilla, Xavier Castellsagué, Ignacio G. Bravo, Michael Pawlita, William G. Quint, Nubia Muñoz, Francesc X. Bosch, Silvia de Sanjosé, , Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide International Journal of Cancer. ,vol. 136, pp. 98- 107 ,(2015) , 10.1002/IJC.28963

Punnee Pitisuttithum, Christine Velicer, Alain Luxembourg, 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV. Expert Review of Vaccines. ,vol. 14, pp. 1405- 1419 ,(2015) , 10.1586/14760584.2015.1089174

Beatriz Serrano, Silvia de Sanjosé, Sara Tous, Beatriz Quiros, Nubia Muñoz, Xavier Bosch, Laia Alemany, Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions European Journal of Cancer. ,vol. 51, pp. 1732- 1741 ,(2015) , 10.1016/J.EJCA.2015.06.001

Suzanne M. Garland, Tak-Hong Cheung, Shelly McNeill, Lone Kjeld Petersen, Josefina Romaguera, Jorge Vazquez-Narvaez, Oliver Bautista, Christine Shields, Scott Vuocolo, Alain Luxembourg, Safety and immunogenicity of a 9-valent HPV vaccine in females 12–26 years of age who previously received the quadrivalent HPV vaccine ☆ Vaccine. ,vol. 33, pp. 6855- 6864 ,(2015) , 10.1016/J.VACCINE.2015.08.059

Timo Vesikari, Nicholas Brodszki, Pierre van Damme, Javier Diez-Domingo, Giancarlo Icardi, Lone Kjeld Petersen, Clément Tran, Stéphane Thomas, Alain Luxembourg, Martine Baudin, A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls Pediatric Infectious Disease Journal. ,vol. 34, pp. 992- 998 ,(2015) , 10.1097/INF.0000000000000773

X. Castellsagué, A.R. Giuliano, S. Goldstone, A. Guevara, O. Mogensen, J.M. Palefsky, T. Group, C. Shields, K. Liu, R. Maansson, A. Luxembourg, S.S. Kaplan, Immunogenicity and safety of the 9-valent HPV vaccine in men Vaccine. ,vol. 33, pp. 6892- 6901 ,(2015) , 10.1016/J.VACCINE.2015.06.088